Compound ID | 784
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Broad spectrum activity including anaerobes |
| Description: | Natural product from Bacillus subtilis ATCC 39320; a macrocyclic polyene lactone phosphate ester |
| Institute where first reported: | Merck & Co., USA |
| Year first mentioned: | 1986 |
| Development status: | Experimental |
| Reason dropped: | Shows to be unstable at different pH's and easily oxidated; little in vivo activity in mice model when administered subcutaneously but was effective through intraperitoneal injection suggesting metabolism of compound and hence preventing its translocation to site of infection |